Froimson Mark

Avg. Two Year Performance

14% Avg. Purchase Return
7% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(2%)4%22%14%
Purchase Success Rate0 of 10 of 11 of 11 of 11 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Pacira Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 14.47K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--